# Preventing traumatic stress–induced behavioral abnormalities in rats with blue light phototherapy

**Authors:** Yi Li, Weiwen Wang, Yizhou Tan, Haixia Qiu, Ying Wang, Jing Zeng, Defu Chen, Hongyou Zhao, Haolin Liu, Ying Gu

PMC · DOI: 10.1038/s41398-026-03981-z · Translational Psychiatry · 2026-03-27

## TL;DR

Blue light therapy reduced anxiety and fear behaviors in rats after traumatic stress, suggesting it could be a non-invasive treatment for PTSD.

## Contribution

This study demonstrates blue light therapy's potential as an early non-invasive intervention for PTSD-related symptoms in a rat model.

## Key findings

- Immediate blue light therapy reduced anxiety-like behaviors in rats exposed to traumatic stress.
- Transcriptomic analysis showed blue light therapy modulated stress-related synaptic pathways in the prefrontal cortex.
- Immediate and combined light therapy groups showed significant improvements in fear behaviors three weeks post-intervention.

## Abstract

Posttraumatic stress disorder (PTSD) is a debilitating mental condition triggered by traumatic stress, and current treatments remain limited. Non-invasive phototherapy has shown promise in mood disorders, yet its efficacy in PTSD—particularly for early intervention and fear symptom mitigation—remains insufficiently explored.

This study aimed to investigate the preventive and therapeutic effects of blue non-invasive phototherapy (470 nm) on PTSD-related anxiety and fear behaviors in a rat model, focusing on neuronal activation and transcriptomic changes in emotion-related brain regions.

Sprague-Dawley (SD) rats (n = 100) were subjected to single inescapable electric foot shock after single prolonged stress procedure (SPS-S). Groups included control (Ctrl), SPS-S, SPS-S + immediate light therapy (SPS-S + I-LT), SPS-S + delayed light therapy (SPS-S + D-LT), and SPS-S + immediate and delayed light therapy combination (SPS-S + ID-LT). Behavioral assessments, including open field test (OFT), elevated plus maze (EPM) and fear conditioning, were conducted at week one and three post-intervention. Immunohistochemical staining for c-Fos expression and RNA sequencing of the medial prefrontal cortex (mPFC) were performed to evaluate neural activation and transcriptomic alterations.

I-LT and ID-LT were associated with reduced anxiety-like behaviors in the OFT and EPM compared with untreated SPS-S-exposed rats (p < 0.001). Improvements in fear-related freezing behavior were observed at 3 weeks in the I-LT group and ID-LT group (p < 0.001), whereas D-LT was associated with anxiolytic effects without significant changes in fear responses. SPS-S exposure was associated with increased c-Fos expression in the infralimbic mPFC, and this elevation was attenuated in animals receiving I-LT or ID-LT. Transcriptomic analyses revealed stress-associated alterations in synapse-related pathways, which were modulated in the I-LT group. Selected synaptic genes were further examined by quantitative real-time PCR.

Blue light phototherapy produced distinct behavioral and molecular signatures in a rat model of traumatic stress. Immediate post-trauma intervention showed stronger associations with fear-related outcomes, supporting the potential relevance of early light-based interventions as a non-invasive adjunctive strategy for traumatic stress management.

## Linked entities

- **Genes:** FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353]
- **Diseases:** posttraumatic stress disorder (MONDO:0005146), PTSD (MONDO:0005146)

## Full-text entities

- **Genes:** Ca3 (carbonic anhydrase 3) [NCBI Gene 54232] {aka Car3}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Apba2 (amyloid beta precursor protein binding family A member 2) [NCBI Gene 83610] {aka Mint2}, Prl (prolactin) [NCBI Gene 24683] {aka Gha1, PRLB, PRLSD1, Prl1a1, Prol, RATPRLSD1}, Snap25 (synaptosome associated protein 25) [NCBI Gene 25012] {aka SNAP-25B, SNAP-25a}, Napb (NSF attachment protein beta) [NCBI Gene 499903] {aka SNAP-beta, Snapb}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, Mat2b (methionine adenosyltransferase 2 non-catalytic beta subunit) [NCBI Gene 683630], Grm8 (glutamate metabotropic receptor 8) [NCBI Gene 60590] {aka Glur8, Gprc1h, Mglur8, mGluR8b, mGlur}, Bhmt (betaine-homocysteine S-methyltransferase) [NCBI Gene 81508], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 24383] {aka BARS-38, Gapd}, Syt6 (synaptotagmin 6) [NCBI Gene 60565], Slc17a6 (solute carrier family 17 member 6) [NCBI Gene 84487] {aka Dnpi, Vglut2}, Amph (amphiphysin) [NCBI Gene 60668] {aka Amph1}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 314322] {aka c-fos}
- **Diseases:** anxiety (MESH:D001007), eye fatigue (MESH:D001248), hyperactivity (MESH:D006948), SAD (MESH:D003865), fear (MESH:C000719212), sleep disturbances (MESH:D012893), mood disorders (MESH:D019964), behavioral abnormalities (MESH:D001523), seasonal affective disorder (MESH:D016574), anxiety disorders (MESH:D001008), EPM (MESH:D006937), premenstrual syndrome (MESH:D011293), PTSD (MESH:D013313), depression (MESH:D003866), HL (MESH:C538324), retinal damage (MESH:D012164), dizziness (MESH:D004244), phototoxicity (MESH:D017484), trauma (MESH:D014947)
- **Chemicals:** water (MESH:D014867), Alexa Fluor 488 (MESH:C000711379), isopropanol (MESH:D019840), DEPC (MESH:D004047), TRIzol (MESH:C411644), DAPI (MESH:C007293), eosin (MESH:D004801), PFA (MESH:C003043), sucrose (MESH:D013395), S (MESH:D013455), hematoxylin (MESH:D006416), -A (MESH:D001151), sodium pentobarbital (MESH:D010424), ethanol (MESH:D000431), Triton X-100 (MESH:D017830), chloroform (MESH:D002725), hydrocortisone (MESH:D006854), paraffin (MESH:D010232), D-LT (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Moloney murine leukemia virus (no rank) [taxon 11801], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039398/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039398/full.md

---
Source: https://tomesphere.com/paper/PMC13039398